This content is from: Local Insights

Singapore: Billion-dollar fund to help companies with strong IP

The Intellectual Property Office of Singapore (IPOS) announced on April 26 2017 the launch of a new billion-dollar fund aimed at helping promising companies to grow and expand into global markets.

The Makara Innovation Fund (MIF), established through a partnership between IPOS and a Singapore-based private equity firm, Makara Capital, will target high growth companies with strong intellectual property and proven business models. It is the first south-east Asian private equity investment fund that sources IP-driven companies internationally and capitalises on cross-border regional expansion.

The MIF is one of several new collaborations with partners in the business and finance community announced by IPOS and the Ministry of Law as part of the IP Hub Master Plan.


The report by the Singapore government's Committee on the Future Economy (CFE) identified IP as a key driver of economic growth. In 2013, the government accepted the 10-year IP Hub Master Plan by IPOS and the Ministry of Law to support the CFE's recommendation to strengthen Singapore's innovation ecosystem and build capabilities to help enterprises innovate and expand.

IP-rich and high-growth-potential companies

The MIF has been created by IPOS through its enterprise engagement arm (IP Value Lab) and Makara Capital. The partnership project will invest SG$30 million to $150 million across 10 to 15 companies from anywhere in the world, including Singapore. These are IP-rich and high-growth potential companies with globally competitive technologies, who will leverage Singapore's IP ecosystem to help them deepen their value creation, compete effectively and expand into the global markets.

The Fund's sector focus includes: urban solutions (logistics, security, waste management, etc), advanced technologies (AI, big data, cybersecurity, nanotech, etc), fintech, alternative energy, healthcare and bio-med. Through this collaboration, the MIF will help to anchor Singapore as a destination for ideas to be translated into assets and revenue.

MoU to help Singapore-based companies drive growth

IPOS also announced that it has signed a new Memorandum of Understanding (MoU) with the Singapore Business Federation (SBF) to work together to assist Singapore-based companies in driving enterprise growth through IP and innovation. The MoU will help 25,000 member companies of the SBF in building IP awareness and competencies, as well as gaining direct access to a suite of IP services from IPOS, such as training, executive education and complimentary IP clinics. It also seeks to help companies take their IP abroad by promoting Singapore IP service providers to overseas companies, and also local companies who wish to expand regionally.

The initiatives in the IP Hub Master Plan are estimated to inject at least SG$1.5 billion into Singapore's economy in the next five years, with further benefits as it catalyses more innovation-driven enterprises. The number of skilled IP experts will be doubled to 1,000 over the next five years to support the growing demand for innovation expertise.

Singapore's IP regime has consistently been rated as one of the best globally. These initiatives also depict the evolution of IPOS beyond the traditional role as an IP registry and regulator towards an innovation agency. With the strong support of the government and IPOS's efforts, we remain confident of the continued development and transformation of Singapore's IP ecosystem.

Wu Zhexuan
Daniel Collopy

Spruson & Ferguson (Asia) Pte Ltd
152 Beach Road
#37-05/06 Gateway East
Singapore 189721
Tel: +65 6333 7200
Fax: +65 6333 7222

The material on this site is for law firms, companies and other IP specialists. It is for information only. Please read our Terms and Conditions and Privacy Notice before using the site. All material subject to strictly enforced copyright laws.

© 2021 Euromoney Institutional Investor PLC. For help please see our FAQs.

Instant access to all of our content. Membership Options | One Week Trial